Keyphrases
Breast Cancer
94%
Breast Cancer Susceptibility Gene 1 (BRCA1)
74%
Jewish
68%
Ashkenazi
66%
Breast
47%
Ashkenazi Jews
46%
Tumor
45%
Colon Cancer Cells
41%
Breast Reconstruction
37%
BRCA1, BRCA2
37%
High-risk Women
36%
Growth Factors
36%
Ovarian Cancer
36%
Liver
34%
Thromboangiitis Obliterans
34%
Jewish Women
32%
BRCA2
32%
Hepatocytes
31%
Extracellular Matrix
30%
Interleukin-2
30%
BRCA mutation
29%
Lymphokine-activated Killer Cells
29%
Mutation Carriers
28%
Hypothyroidism
27%
High Risk
26%
Breast Cancer Patients
26%
Breast Cancer Risk
26%
Tumor Necrosis Factor-α
24%
Familial Breast Cancer
24%
Bleeding
24%
Inherited Predisposition
23%
Israel
22%
Neoadjuvant Chemotherapy
22%
Buerger's Disease
22%
Germline mutation
22%
Insulin-like
22%
Breast Carcinoma
22%
Abdominal
21%
Tyrosine Phosphorylation
21%
BRCA2 mutation
20%
SHEBA
20%
Non-carriers
20%
Laparoscopic Sleeve Gastrectomy
20%
Insulin
20%
Magnetic Resonance-guided Focused Ultrasound Surgery
20%
Stopped Flow
20%
Magnetic Resonance Imaging
19%
Polymorphism
19%
ErbB2
19%
Lumpectomy
19%
Medicine and Dentistry
Breast Cancer
100%
Neoplasm
69%
Surgery
38%
Disease
34%
BRCA1
31%
Quadrantectomy
29%
Bleeding
27%
Cancer Cell
26%
Symptom
25%
Neoadjuvant Chemotherapy
22%
Extracellular Matrix
22%
Colon Cancer Cell Line
21%
Nuclear Magnetic Resonance
21%
Laparoscopic Sleeve Gastrectomy
20%
Rectum Cancer
20%
Obliterating Endarteritis
20%
Ultrasound Surgery
20%
Breast Carcinoma
19%
Infection
19%
Colon Cancer
19%
Catheter Ablation
19%
Lumpectomy
18%
Malignant Neoplasm
18%
Heparin
18%
Tumor Cell
18%
Breast Tumor
17%
BRCA2
17%
Disease Predisposition
17%
Breast Biopsy
17%
Ovarian Cancer
16%
Symptomatic Treatment
15%
Hepatocyte
15%
Nodular Melanoma
15%
Mastectomy
15%
Sentinel Node
14%
Growth Factor
13%
Doxorubicin
13%
Metastatic Melanoma
13%
Surgical Anastomosis
13%
Carcinoid
13%
Pelvic Floor Rehabilitation
13%
Somatomedin C Receptor
13%
Growth Factor Receptor
13%
Sleeve Gastrectomy
13%
Counseling
13%
Chemoprophylaxis
13%
Preventive Mastectomy
13%
Cell Therapy
13%
Quality of Life
13%
Retroperitoneal Lymph Node Dissection
12%